Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY20.43 CNY
Change Today -0.20 / -0.97%
Volume 1.5M
As of 9:57 PM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin zhong xin pharm co-a (600329) Snapshot

Open
CNY20.65
Previous Close
CNY21.27
Day High
CNY20.91
Day Low
CNY20.30
52 Week High
03/26/15 - CNY21.75
52 Week Low
04/1/14 - CNY11.94
Market Cap
12.4B
Average Volume 10 Days
12.6M
EPS TTM
CNY0.49
Shares Outstanding
539.3M
EX-Date
--
P/E TM
42.0x
Dividend
CNY0.15
Dividend Yield
0.24%
Current Stock Chart for TIANJIN ZHONG XIN PHARM CO-A (600329)

Related News

No related news articles were found.

tianjin zhong xin pharm co-a (600329) Related Businessweek News

No Related Businessweek News Found

tianjin zhong xin pharm co-a (600329) Details

Tianjin Zhongxin Pharmaceutical Group Corporation Limited, an investment holding company, produces and sells traditional Chinese medicines, western medicines, and healthcare products primarily in the People's Republic of China. It offers Chinese patent medicines, Chinese medicinal materials, pharmaceutical raw materials and western medicines, bioengineering drugs, nutritious and health products, etc. The company’s principal products include Suxiao Jiuxin Wan, Huoxiang Zhengqi Ruan Jiaonang, Zilong Jin Pian, Jinqi Jiangtang Pian, Weichang An Wan, Biqi Jiaonang, a-2b Interferon, Gliclazide, Te Zi She Fu, etc. It is also involved in the wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products. In addition, the company sells medicinal products under its own brand and other brands to wholesalers. Tianjin Zhongxin Pharmaceutical Group Corporation Limited was founded in 1992 and is based in Tianjin, China.

Founded in 1992

tianjin zhong xin pharm co-a (600329) Top Compensated Officers

Executive Chairman, General Manager and Chair...
Total Annual Compensation: CNY1.0M
Chief Financial Officer
Total Annual Compensation: CNY500.0K
Executive Director
Total Annual Compensation: CNY757.3K
Chief Engineer, Deputy General Manager, Execu...
Total Annual Compensation: CNY500.0K
Compensation as of Fiscal Year 2013.

tianjin zhong xin pharm co-a (600329) Key Developments

Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Board Meeting, Mar 30, 2015

Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Board Meeting, Mar 30, 2015. Agenda: To approve the chairman report for fiscal 2014; to approve the board of directors' report for fiscal 2014; to approve the company's audited financial report for fiscal 2014; to approve the scheme of profit distribution policy of the company for fiscal 2014; to approve the company's report on the social responsibilities for fiscal 2014; to approve the company's self-evaluation report on the internal control for fiscal 2014; to approve the report from independent directors for fiscal 2014; to approve the report of performance from audit committee for fiscal 2014; to approve the aggregate remuneration for directors of company for fiscal 2014; to approve the appointment of Mr. Qiang Zhi yuan as independent director of the company; to approve the appointment of Ms. Wang lei as a director of the company; and to consider other matter also.

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Proposes Final Dividend for 2014; Announces Audited Group Earnings Results for the Year Ended December 31, 2014

The directors of Tianjin Zhongxin Pharmaceutical Group Corporation Limited proposed the final dividend for 2014 of RMB 110,896,308 on the basis of RMB 1.5 for every 10 shares in the capital of the company. Such proposed declaration of dividends will be subject to approval by shareholders at the forthcoming annual general meeting to be held on 15 May 2015. The company announced audited group earnings results for the year ended December 31, 2014. For the year, the group reported revenue of RMB 7,086,879,000 against RMB 6,010,137,000 a year ago. Profit before income tax was RMB 430,879,000 against RMB 417,426,000 a year ago. Profit, net of tax attributable to owners of the parent was RMB 357,801,000 against RMB 352,264,000 a year ago. Basic and diluted earnings per share were RMB 0.48 against RMB 0.48 a year ago. Net cash flow from operating activities was RMB 269,384,000 against RMB 217,257,000 a year ago. Purchase of property, plant and equipment, intangibles, land use rights and investment property was RMB 70,151,000 against RMB 72,422,000 a year ago. The increase in revenue was due to strengthening the control of the marketing process, and creating innovative marketing models to boost sales through brand influence.

Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Board Meeting, Feb 16, 2015

Tianjin Zhongxin Pharmaceutical Group Corporation Limited, Board Meeting, Feb 16, 2015. Agenda: To provide corporate guarantee in relation to the general credit facility provided to one of the company's subsidiaries, namely, Chengdu Zhongxin Pharmaceutical Co., Ltd; and to consider the appointment of Ms. Xie Xi as company securities affairs representative.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600329:CH CNY20.43 CNY -0.20

600329 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
American Oriental Bioengineering Inc $3.99 USD 0.00
View Industry Companies
 

Industry Analysis

600329

Industry Average

Valuation 600329 Industry Range
Price/Earnings 43.0x
Price/Sales 2.3x
Price/Book 5.8x
Price/Cash Flow 31.1x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN ZHONG XIN PHARM CO-A, please visit www.zhongxinp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.